Toyama, Japan

Issei Doi

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Fujifilm Corporation, Toyama Chemical Co., Ltd.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Issei Doi. Retrieved from https://idiyas.com/inventor/issei-doi-2ug8qafs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Issei Doi: Innovator in Lipid Particle Technology

Introduction

Issei Doi is a prominent inventor based in Toyama, Japan. He has made significant contributions to the field of lipid particle technology, particularly in the encapsulation and delivery of nucleic acids. With a total of 3 patents to his name, Doi's work is paving the way for advancements in medical and biotechnological applications.

Latest Patents

One of Issei Doi's latest patents focuses on a compound or salt thereof that constitutes lipid particles. The objective of this invention is to achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. The patent describes a compound represented by a specific formula, where various components are defined to enhance the effectiveness of the lipid particles in delivering nucleic acids.

Career Highlights

Throughout his career, Issei Doi has worked with notable companies such as Fujifilm Corporation and Toyama Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of lipid technology and innovation.

Collaborations

Issei Doi has collaborated with esteemed colleagues, including Shintaro Tanabe and Masahiko Yamamoto. These partnerships have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Issei Doi's work in lipid particle technology exemplifies the importance of innovation in the field of biotechnology. His patents and collaborations highlight his commitment to advancing the delivery of nucleic acids, which could have significant implications for future medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…